Primary Chest Wall Glomus Tumor Resected by Video-Assisted Thoracoscopic Surgery: A Case Report with 10-Year Follow-up Authors: Noritake Kikunishi, Tetsukan Woo, Daisuke Noma, Atsuko Osawa, Takashi Nakayama, Aya Saito Published: 2026 ABSTRACT ABSTRACTINTRODUCTIONGlomus tumors are rare perivascular neoplasms that typically occur in the distal extremities. Their occurrence in the chest wall is extremely rare, with only 13 cases previously reported in the English literature. Herein, we report a unique case of a primary chest wall glomus tumor in a patient who presented with severe, rapidly worsening back pain, underwent 18F-fluorodeoxyglucose-PET/CT (FDG-PET/CT) evaluation, and experienced complete pain resolution following thoracoscopic resection.CASE PRESENTATIONA 65-year-old man presented to our emergency department with a 1-month history of progressively worsening right posterior back pain. Contrast-enhanced CT revealed a 20 × 13-mm well-enhanced oval mass in the right posterior chest wall at the level of the ninth rib. MRI demonstrated heterogeneous intensity on T2-weighted images. FDG-PET/CT showed low tumor uptake with a maximum standardized uptake value (SUVmax) of 2.2. This finding was considered adjunctive metabolic information that did not strongly suggest a highly aggressive malignancy; however, it was insufficient to exclude malignancy or establish a definitive diagnosis. To achieve a definitive diagnosis and alleviate the severe pain, surgical resection was performed via 4-port video-assisted thoracoscopic surgery (VATS). The tumor was completely excised with clear margins. Histopathological and immunohistochemical analyses confirmed the diagnosis of a benign glomus tumor, with diffuse positivity for smooth muscle actin (SMA) and a Ki-67 labeling index of less than 1%. The patient’s severe back pain completely resolved immediately after surgery, and he remained completely asymptomatic with no evidence of recurrence at the 10-year follow-up.CONCLUSIONSAlthough exceedingly rare, glomus tumors should be included in the differential diagnosis of painful chest wall tumors. FDG-PET/CT may provide adjunctive information regarding metabolic activity during preoperative assessment; however, its findings should be interpreted cautiously and cannot replace histopathological evaluation. To the best of our knowledge, this is the first reported case of a chest wall glomus tumor evaluated with FDG-PET/CT. Complete surgical resection remains essential for definitive diagnosis and symptom relief, and minimally invasive resection via VATS may be an effective approach when complete resection is feasible. Abbreviations 18F-fluorodeoxyglucose PET/CT hematoxylin and eosin numerical rating scale smooth muscle actin maximum standardized uptake value visual analogue scale video-assisted thoracoscopic surgery INTRODUCTION Glomus tumors are rare perivascular neoplasms arising from the neuromyoarterial glomus body, which functions as a specialized form of arteriovenous anastomosis involved in thermoregulation. They account for approximately 1%–2% of soft tissue tumors and typically manifest in the subungual region of the hands. According to the latest World Health Organization (WHO) Classification of Tumours (5th edition, 2020), glomus tumors are categorized within the group of pericytic (perivascular) tumors.1) The occurrence of glomus tumors in the chest wall is exceedingly rare. To date, only 13 cases have been reported in the English literature.2–14) Due to their rarity, deep-seated location, and lack of the classic clinical triad (localized pain, pinpoint tenderness, and cold hypersensitivity), these tumors are often misdiagnosed as other mesenchymal tumors such as schwannomas or hemangiomas,14,15) leading to delayed diagnosis and prolonged patient suffering. Herein, we report a unique case of a primary chest wall glomus tumor presenting with severe, rapidly worsening back pain that necessitated emergency department evaluation. This case is notable for 3 reasons: (1) it is, to the best of our knowledge, the first reported chest wall glomus tumor evaluated with FDG-PET/CT; (2) the pain completely resolved immediately after surgery following minimally invasive resection; and (3) the tumor size of 2.0 cm with deep location satisfied the criteria for uncertain malignant potential, yet was confirmed benign by a very low Ki-67 index (<1%) and absence of nuclear atypia. CASE PRESENTATION A 65-year-old man had been experiencing right posterior back pain for 1 month. The pain was somatic in character, without positional dependency, respiratory variation, or neurological symptoms, and progressively worsened to a severity requiring emergency department evaluation. He had no relevant past medical history. Physical examination revealed no skin lesions, no palpable mass, and no tenderness on the chest wall. Laboratory findings were unremarkable. Contrast-enhanced CT demonstrated a 20 × 13-mm oval-shaped mass in the right posterior chest wall at the level of the ninth rib, exhibiting heterogeneous density with strong enhancement (Fig. 1A). MRI showed heterogeneous intensity on T2-weighted images (Fig. 1B) and fat-suppressed T2-weighted MRI clearly delineating the tumor from the surrounding fatty tissue (Fig. 1C). FDG-PET/CT demonstrated weak uptake in the tumor, with an SUVmax of 2.2 (Fig. 1D). These imaging findings were suggestive of a benign or low-grade vascular or neurogenic tumor; however, a definitive preoperative diagnosis could not be established, as the differential diagnosis included a broad range of entities such as schwannoma, hemangioma, solitary fibrous tumor, angioleiomyoma, pericytic tumors, and low-grade sarcomas. Radiological findings of the chest wall tumor. (A) Contrast-enhanced CT scan showing a well-circumscribed, heterogeneously enhanced oval mass in the right posterior chest wall at the level of the ninth rib (arrow). (B) T2-weighted MRI revealing heterogeneous high signal intensity in the tumor. (C) Fat-suppressed T2-weighted MRI clearly delineating the tumor from the surrounding fatty tissue. (D) FDG-PET/CT fusion image showing mild accumulation in the tumor with a SUVmax of 2.2 (arrow). FDG-PET/CT 18F-fluorodeoxyglucose PET/CT; SUVmax, maximum standardized uptake value For definitive diagnosis and treatment, surgical resection was performed via 4-port VATS with the patient in the left lateral decubitus position. A 10-mm camera port was placed in the eighth intercostal space at the midaxillary line. Three additional 5-mm working ports were placed in the fifth intercostal space at the anterior axillary line, the sixth intercostal space at the posterior axillary line, and the seventh intercostal space at the anterior axillary line. The tumor was identified as a soft, circumscribed, and highly vascular mass located in the extrapleural space anterior to the intercostal muscles in the right posterior chest wall at the level of the ninth rib, adherent to the parietal pleura, without evident attachment to the intercostal neurovascular bundle or periosteum based on intraoperative findings (Fig. 2A). The precise site of origin could not be determined, but the tumor was considered to arise from the extrapleural soft tissue. It was completely resected en bloc with the overlying parietal pleura, achieving clear resection margins using endoscopic scissors and bipolar coagulation forceps. Pathological examination confirmed microscopically negative margins, although the exact margin distance was not measured. Estimated blood loss was minimal, and no rib resection was required. Intraoperative and macroscopic findings. (A) Thoracoscopic view showing a soft, circumscribed, and highly vascular tumor (arrow) adherent to the parietal pleura. (B, C) Macroscopic appearance of the resected specimen showing a heterogeneous cut surface with white to brown areas and focal hemorrhages. Macroscopically, the cut surfaces of the tumor were heterogeneous, white to brown in color, with focal hemorrhages (Fig. 2B and 2C). Histologically, the tumor consisted of solid or sheet-like nests of small, uniform, rounded cells with centrally placed round nuclei and amphophilic to lightly eosinophilic cytoplasm, surrounding abundant small blood vessels (Fig. 3A and 3B). Neither marked nuclear atypia nor atypical mitotic figures were observed, and the Ki-67 labeling index was less than 1% (Fig. 3C). Immunohistochemical analysis revealed that the tumor cells were diffusely positive for SMA (Fig. 3D), but negative for CD34, S-100, HMB-45, desmin, epithelial membrane antigen, AE1/3, melan-A, and calretinin (Fig. 3E and 3F). These findings confirmed the diagnosis of a benign glomus tumor of the chest wall.1,16) Histopathological and immunohistochemical findings. (A, B) H&E staining showing the tumor composed of nests of small, uniform, rounded cells with centrally placed round nuclei and amphophilic to lightly eosinophilic cytoplasm. The tumor cells are arranged around abundant small blood vessels in a solid or sheet-like pattern (A, ×100; B, ×200). (C) The Ki-67 labeling index was less than 1% (×200). (D) Immunohistochemical staining showing diffuse positivity for SMA (×200). (E) Negative staining for CD34 (×200). (F) Negative staining for S-100 protein (×200). H&E, hematoxylin and eosin; SMA, smooth muscle actin The patient’s severe back pain completely resolved immediately after surgery. Although formal pain scores (numerical rating scale [NRS]/visual analogue scale [VAS]) were not prospectively recorded, no additional analgesics beyond routine postoperative loxoprofen were required. The patient reported complete resolution of the deep posterior back pain that had prompted emergency department evaluation, which was clearly distinguishable from expected postoperative wound pain at the port sites. He had an uneventful postoperative recovery and was discharged 1 week after surgery. The patient has been followed up annually with blood tests, chest radiography, and CT. At the last follow-up in February 2026, 10 years after surgery, he remained completely asymptomatic with no clinical or radiological evidence of recurrence. DISCUSSION Glomus tumors of the chest wall are exceedingly rare mesenchymal neoplasms. We performed a literature search of PubMed and Google Scholar using the following terms: “glomus tumor,” “glomangioma,” “glomangiomyoma,” “chest wall,” “thoracic wall,” and “intercostal.” The last search was performed in March 2026. We included cases of primary glomus tumors arising from the chest wall, including cutaneous, subcutaneous, intramuscular, intercostal, and subpleural lesions. Cases arising primarily from the lung, mediastinum, or visceral pleura without clear chest wall origin were excluded. English-language articles and non-English articles with sufficient English abstracts were reviewed. Including the present case, 14 cases met these criteria and were summarized in Table 1.2–14) Among these, the male-to-female ratio was 10:3, and the mean age at diagnosis was approximately 46 years (range, 19–67 years). The mean symptom duration before diagnosis was notably long (5.4 years),14) reflecting the diagnostic challenges posed by this entity. In the present case, however, the pain rapidly worsened over 1 month and prompted emergency department evaluation, a clinical course more acute than that of most previously reported cases. Table 1Comparison of reported cases of glomus tumors of the chest wallAuthor (year)SexAge (years)Symptom durationChief symptomSkin involvementLocationSize (cm)Preoperative imagingHistological subtypeSurgical approachBenign/malignantOutcome (follow-up)Schneller2) (2001)M3010 yearsPainNRMultifocal; left posterior intercostal spacesUp to 9 (multiple)CTGlomangiomyomaOpen resectionBenign (multifocal)NRTsuruta et al.3)† (2003)F195 yearsPainNoRight anterior, 3rd intercostal space2.0US, CT, MRI: T2 hyperintenseSolid glomus tumorOpen resectionUncertain malignant potential‡No recurrence (1 year)Neelaiah and Suryanarayanarao4) (2005)M462 yearsPainBluish-red noduleSubcutaneous anterior chest wall0.5 × 0.75NRSolid glomus tumorNRNRNRUchiyama et al.5)† (2011)M5010 yearsPainNRRight 3rd intercostal space (+ buttocks)NRCTSolid glomus tumorResection (incl. 4th rib)Uncertain malignant potential‡NRVenugopal6) (2015)M676 yearsPain, cold sensitivityVague swellingLeft scapula area2.0NRSolid glomus tumorOpen excisionBenignNRTemiz et al.7) (2016)NRNRNRPainPurple-colored hard noduleSternal projection (subcutaneous)0.5–1.0USSolid glomus tumorOpen excisionBenignNo recurrence (1 year)Yim et al.8) (2016)M41NRPainNRRight paraspinal area6.3 (->19 at recurrence)MRISolid glomus tumorOpen resection × 2Malignant transformation at recurrenceRecurrence at 6 months and 4 yearsKambhampati and Kambhampati9) (2018)M472 yearsPainPainful purple papuleLeft anterior chest wall (subcutaneous)1.0 × 0.4USSolid glomus tumorOpen excisionBenignNo recurrence (6 months)Zanjani et al.10) (2021)M6315 yearsPain, cold sensitivity, limited shoulder movementAxillary lumpLeft lateral chest wall5.0MRI: T2 hyperintenseGlomangiomaOpen resectionBenignNo recurrence (19 months)Alyaseen et al.11) (2021)M357 yearsPain, cold sensitivityBluish papuleRight lateral chest wall (cutaneous)1.0NRGlomangiomaOpen excisionBenignNRBhalchandra Londhe et al.12) (2021)F27NRPain (scapulothoracic impingement)NoRight posterior chest wall muscles2.0 × 1.0 × 1.9MRI: T2 hyperintenseSolid glomus tumorOpen resectionBenignNo recurrence (1 year)Engle et al.13) (2024)F676 monthsNRSkin-colored subcutaneous noduleAnterior chest wall (+ lung metastases)NRCTSolid glomus tumorRadiation + pembrolizumabMalignant (lung metastases)Partial remissionJagelavicius et al.14) (2025)M421 yearIntermittent pain under right scapulaNoRight posterior chest wall, 9th intercostal space (subpleural)3.8 × 1.8CT: well-defined; MRI: T1 hyperintense, T2 isointense, contrast-enhancedGlomangiomaVATSBenignNo recurrence (3 months) Present case M651 month (rapidly worsening; ER visit)Severe right posterior back painNoRight posterior chest wall, 9th rib level (deep-seated)2.0 × 1.3CT: heterogeneous strong enhancement; MRI: T2 heterogeneous; FDG-PET: SUVmax 2.2Solid glomus tumor4-port VATSBenign (Ki-67 <1%, no atypia)Complete pain resolution immediately after surgery; no recurrence (10 years)Bold row indicates the present case.†Only abstract available in English.‡Classified as uncertain malignant potential based on deep location and size ≥2 cm per Folpe criteria16); full pathological details not reported.ER, emergency room; FDG-PET/CT, 18F-fluorodeoxyglucose PET/CT; NR, not reported; SUVmax, maximum standardized uptake value; VATS, video-assisted thoracoscopic surgery Comparison of reported cases of glomus tumors of the chest wall Bold row indicates the present case. †Only abstract available in English. ‡Classified as uncertain malignant potential based on deep location and size ≥2 cm per Folpe criteria16); full pathological details not reported. ER, emergency room; FDG-PET/CT, 18F-fluorodeoxyglucose PET/CT; NR, not reported; SUVmax, maximum standardized uptake value; VATS, video-assisted thoracoscopic surgery Reported chest wall glomus tumors can be broadly divided into superficial lesions involving the skin or subcutaneous tissue and deeply located lesions arising from the intercostal, muscular, or subpleural chest wall. Superficial lesions often present with visible skin discoloration, a palpable painful nodule, or cold sensitivity, whereas deeply located lesions may lack the classic triad and present only with nonspecific deep chest wall or back pain. The present case belonged to the deeply located group, as no skin lesion or palpable mass was observed and the tumor was detected only by cross-sectional imaging. When the tumor is located in deeper layers, as in the present case, nonspecific deep pain is the predominant symptom, and the classic clinical triad—localized pain, pinpoint tenderness, and cold hypersensitivity—is frequently absent.1,16) The intense pain characteristic of glomus tumors is attributed to the rich innervation of the glomus body and the release of neuropeptides, including substance P, from unmyelinated nerve fibers in and around the tumor.17,18) This neurochemical mechanism likely explains the dramatic and immediate resolution of pain following complete tumor excision observed in the present case and in several previously reported cases.4,10,12) The mechanism underlying the rapid clinical deterioration in the present case remains speculative; however, the focal hemorrhagic areas identified macroscopically suggest that intratumoral hemorrhage may have acutely increased local pressure on the richly innervated glomus body, thereby contributing to the acute exacerbation of pain. Preoperative imaging is helpful but rarely diagnostic for chest wall glomus tumors. On MRI, glomus tumors classically appear hyperintense on T2-weighted images due to their high vascular content.18) In the present case, the tumor showed heterogeneous T2 signal intensity, which may reflect the focal hemorrhagic areas observed macroscopically. To our knowledge, FDG-PET/CT has not been previously reported in any case of chest wall glomus tumor. In our patient, the low SUVmax of 2.2 was considered adjunctive metabolic information that did not strongly suggest a highly aggressive malignancy; however, it was insufficient to exclude malignancy or establish a definitive diagnosis. The decision to proceed with minimally invasive diagnostic and therapeutic resection was based on the overall clinical context, including the small, well-circumscribed tumor, the absence of radiological evidence of invasion, and the need for both definitive diagnosis and pain relief. Benign neurogenic tumors such as schwannomas may frequently exhibit high FDG uptake, whereas some low-grade sarcomas may show low accumulation. There is currently no established SUVmax threshold or high-level evidence for using PET/CT to determine the surgical approach for glomus tumors. The definitive confirmation of benign nature relied on the Ki-67 labeling index of less than 1% and the absence of nuclear atypia, rather than the preoperative imaging findings alone. These findings suggest that FDG-PET/CT may serve as supportive data in the preoperative workup of deep-seated chest wall tumors of uncertain etiology, while acknowledging that its role remains supplementary rather than definitive. Regarding malignant potential, Folpe et al. and the WHO classification propose that a glomus tumor is considered malignant if it is both deeply located and larger than 2 cm, while it is considered to have uncertain malignant potential if it meets only one of these criteria, or shows high mitotic activity.1,16) In the present case, the tumor was deeply located, thereby satisfying the criterion for uncertain malignant potential. However, the complete absence of nuclear atypia, absence of atypical mitotic figures, and an extremely low Ki-67 labeling index (<1%) confirmed its benign nature. This case highlights the importance of thorough histopathological evaluation, including Ki-67 assessment, in deep-seated chest wall tumors. Complete surgical resection is generally accepted as the mainstay for both diagnosis and treatment of glomus tumors.14) Incomplete resection has been associated with recurrence rates of 12%–33%.14,16) In the present case, 4-port VATS enabled complete tumor excision with clear margins and minimal invasiveness, without requiring rib resection. VATS has now been reported in 2 chest wall glomus tumor cases, including ours,14) and may be an effective approach for selected posteriorly located, deep-seated tumors when complete resection is feasible. CONCLUSIONS Although exceedingly rare, glomus tumors should be included in the differential diagnosis of painful chest wall masses, even when the clinical presentation is acute. FDG-PET/CT may provide adjunctive information regarding metabolic activity during preoperative assessment; however, its findings should be interpreted cautiously and cannot replace histopathological evaluation. Complete surgical resection remains essential for definitive diagnosis and symptom relief, and minimally invasive resection via VATS may be an effective approach when complete resection is feasible.